<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EA3B9AB7-23D9-4DF8-87CD-51614A87D13F"><gtr:id>EA3B9AB7-23D9-4DF8-87CD-51614A87D13F</gtr:id><gtr:name>Sixth Framework Programme (FP6)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EA3B9AB7-23D9-4DF8-87CD-51614A87D13F"><gtr:id>EA3B9AB7-23D9-4DF8-87CD-51614A87D13F</gtr:id><gtr:name>Sixth Framework Programme (FP6)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EEA90A41-FE78-4648-A169-978B7D07858E"><gtr:id>EEA90A41-FE78-4648-A169-978B7D07858E</gtr:id><gtr:firstName>Assan</gtr:firstName><gtr:surname>Jaye</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1A46E510-77C4-4CE0-AF3F-EA0E2CC93CDE"><gtr:id>1A46E510-77C4-4CE0-AF3F-EA0E2CC93CDE</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Vincent</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CD6AA220-DB51-4206-BA46-42D1AC9C4DBD"><gtr:id>CD6AA220-DB51-4206-BA46-42D1AC9C4DBD</gtr:id><gtr:firstName>Tumani</gtr:firstName><gtr:surname>Corrah</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A900_1125"><gtr:id>2FA620FB-4136-4D39-A711-8CDE0765D936</gtr:id><gtr:title>West Africa Collaboration ? Caio HIV-2 Community Cohort</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A900_1125</gtr:grantReference><gtr:abstractText>MRC, The Gambia unit, established a unique HIV-2 Community cohort in a remote village in Northern Guinea Bissau about 20 years ago which has continued to support investigations on why and how individuals with this type of HIV infection are different from those with HIV-1 infection and behave like normal people who live long without any sign of disease. Numerous follow up data are being collected from these infected individuals including from normal healthy people and those infected with HIV-1 to allow comparison and follow-up studies. Information from these studies will help us understand why some people can be resilient to HIV infection and provide a clue to making a vaccine that will prevent against the more deadly HIV-1 infection. The Caio database is now merged with other HIV databases of cohorts in West African Institutions such as Senegal, Gambia and Guinea Bissau as part of the MRC West Africa collaboration initiative. This will permit collaboration between institutions in West Africa and MRC to strengthen on-going investigations on HIV.</gtr:abstractText><gtr:technicalSummary>Caio community HIV-2 Cohort was set up by the MRC Unit in the Northern part of Guinea Bissau in 1989 that has supported the studies of the natural history and immune-pathogeneses of HIV-2 infection. Caio Community cohort is a unique HIV cohort and the only one with HIV-2 cases-sex and age-matched controls in Africa. MRC invested in this cohort when the first sero-survey was done in 1989 and subsequent second and third sero-survey in 1997 and 2007 respectively. These activities built a well characterised cohort that had informed the natural history of HIV-2. HIV-2 genetic make-up is about 60% similar to that of HIV-1 infection but unlike HIV-1, majority of HIV-2 infected individuals are long term non progressors with high CD4+ count and low or undetectable viral load. The MRC collected data from the single tribal homogenous population continue to support the immunogenetics and pathogenesis studies for the understanding of the mechanisms of HIV disease control in the HIV-2 that can unravel immune correlates of protection for HIV-1 vaccine design. The quest for HIV vaccine continues to be elusive. HIV-2 still serves as an invaluable model to unravel the secretes of HIV non progression and protection and especially at a time when recent epidemiological data has pronounced a potential protective effect of HIV-2 on HIV-1 progression. The invaluable longitudinal database of this cohort has now been integrated into the amalgamated West Africa Collaboration (WAC) database and is being exploited by the MRC created regional network to study the genetic and immunologic attributes of HIV control. The platform collaborates with the Ministry of Health of Guinea Bissau to assist in its anti-retroviral therapy program. MRC Caio also engages in Community health education using the ?Stepping Stones method? for prevention of sexually transmitted diseases and in social studies relating to sex work and risk factors for the spread of HIV. Recently concluded research work includes the interaction and survival analyses of HTLV and HIV-2 co-infections and the study of neurocognitive impairment, myelopathy and peripheral neuropathy in HIV-2.</gtr:technicalSummary><gtr:fund><gtr:end>2013-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2559204</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sixth Framework Programme (FP6)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>WANETAM and WANETAM Plus Consortium</gtr:description><gtr:id>ACC38B97-8185-461A-BFFB-45F177318B41</gtr:id><gtr:impact>Multidicplinary network - ECTP funded WEst African Nodes of Excellence in Clinical Trial for HIV, TB and Malaria</gtr:impact><gtr:outcomeId>cMPSQ4HzH1a-2</gtr:outcomeId><gtr:partnerContribution>Training for capacity building on other discipline such as Malaria</gtr:partnerContribution><gtr:piContribution>- Training for excellence in clinical trial
- Harmonisation of HIV training protocols
- Building capacity in laboratory skills and in Biomedical Equipment Maintenance</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bandim Health Project (BHP)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>WANETAM and WANETAM Plus Consortium</gtr:description><gtr:id>5793FD09-9F10-4F4D-9FF6-71B0FCCC39C1</gtr:id><gtr:impact>Multidicplinary network - ECTP funded WEst African Nodes of Excellence in Clinical Trial for HIV, TB and Malaria</gtr:impact><gtr:outcomeId>cMPSQ4HzH1a-1</gtr:outcomeId><gtr:partnerContribution>Training for capacity building on other discipline such as Malaria</gtr:partnerContribution><gtr:piContribution>- Training for excellence in clinical trial
- Harmonisation of HIV training protocols
- Building capacity in laboratory skills and in Biomedical Equipment Maintenance</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>457CFB93-9513-4365-9349-2BF805115A7A</gtr:id><gtr:title>NeuroAIDS in Africa.</gtr:title><gtr:parentPublicationTitle>Journal of neurovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2684ef032dff40c6e7bc8f562b528f82"><gtr:id>2684ef032dff40c6e7bc8f562b528f82</gtr:id><gtr:otherNames>Robertson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1355-0284</gtr:issn><gtr:outcomeId>pm_15883_23_20500018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21C15840-87C0-4B6F-9B46-D1454C6CD9DB</gtr:id><gtr:title>Effect of HIV-2 infection on HIV-1 disease progression.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b98c961b0315faf69d0f7b5f9bb76c3d"><gtr:id>b98c961b0315faf69d0f7b5f9bb76c3d</gtr:id><gtr:otherNames>Vannberg FO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_15883_23_23150975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>456E1561-C19A-4CD6-A902-BC4DBCF731C5</gtr:id><gtr:title>CD4 intragenic SNPs associate with HIV-2 plasma viral load and CD4 count in a community-based study from Guinea-Bissau, West Africa.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b57f3faab5ebc7c5cb4b1e9f15656da1"><gtr:id>b57f3faab5ebc7c5cb4b1e9f15656da1</gtr:id><gtr:otherNames>Hennig BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>pm_15883_23_20924289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D49461FA-8959-47D7-A329-86003170E543</gtr:id><gtr:title>Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.</gtr:title><gtr:parentPublicationTitle>Journal of neurovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97dd63dbc2eb7f096bf36e1a1d6e2814"><gtr:id>97dd63dbc2eb7f096bf36e1a1d6e2814</gtr:id><gtr:otherNames>Choi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1355-0284</gtr:issn><gtr:outcomeId>pm_15883_23_21424866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC075F8F-DA21-4EB3-9DBD-9FAC5D1FA522</gtr:id><gtr:title>Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_15883_23_23032414</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A900_1125</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>